(TCEO) and dimethyl sulfide10 or carbonyl cyanide.11 Free
N-H containing compounds gave comparable enantiose-
lection to their protected congeners with only a moderate
decrease in yield (entries 1-4). Additional protection/
deprotection steps might offset decreases in yield associ-
ated with utilizing free N-H compounds in multistep
synthesis. Alkyl and silyloxymethyl ether substituents on
the alkene gave good yields and enantioselectivity (entries
3-9). Adding a methoxy group para to the cyanoforma-
mide (entries 7-9) increased yield and enantioselectivity
compared to their hydrogen counterparts (entries 2, 5, and
7). Notably, our use of chiral ligand L during the
cyanoamidation of 4 and 12 (entries 1 and 5) gave us much
higher enantiomeric excesses compared to previous work,
which used a commercially available ligand5 (88% vs
75%, and 97% vs 68%, respectively).
We highlighted the synthetic utility of cyanoamidation in
the total syntheses of (+)-horsfiline and (-)-coerulescine.13,14
A synthetic challenge of these alkaloids is the well-known,
acid-promoted, racemization of the quaternary stereocenter
via retro-Mannich/Mannich reactions (Scheme 2). Therefore,
Scheme 2
.
Acid-Promoted Retro-Mannich/Mannich
Racemization of Horsfiline
We assigned absolute stereochemistry of a cyanoamidation
product via chemical correlation with (-)-esermethole
(Scheme 1).2b Beginning with ester 22,12 two methyl groups
enantioselective routes require endgame strategies avoiding
the use of acid. In our approach, we envisioned that
mesylates, such as 37/38 (Scheme 3), could be converted to
the desired alkaloids in a one-pot chemoselective nitrile
reduction, which would cascade with cyclization and reduc-
tive amination via 39/40.
Scheme 1
.
Assignment of Absolute Configuration via Chemical
To realize the above approach, we began our syntheses
with the N-Boc-protected 2-bromoanilines 26/27. Boc-
protected bromoaniline 26 was produced in one step from
the commercially available 2-bromoaniline, while 27 was
available in two steps from commercially available 4-meth-
oxyaniline.15 Preparation of alkenes 31/32 proceeded with
use of a Pd-catalyzed Suzuki coupling16 of aryl boranes 28/
29 and iodoalkene 30.17 Boc-deprotection with TBSOTf in
2,6-lutidine generated the free anilines in 90% yield for both
substrates. We then prepared the corresponding cyanofor-
mamides using TCEO and dimethyl sulfide10 to give 33/34.
C-CN activation of cyanoformamides 35/36 provided the
corresponding oxindoles bearing a C3 silyloxymethyl group
with excellent enantioinduction. The silyl ethers (35/36) were
deprotected with TBAF, and the resulting alcohols were
converted to the corresponding mesylates (37/38). One-pot
reductive cyclization to form the spirocyclic skeleton was
readily accomplished by reaction of the nitriles with NaBH4/
CoCl2·6H2O,18,19 followed by reductive amination upon
addition of CH2O. We obtained (-)-coerulescine (ee 91%)
and (+)-horsfiline (ee 99%) in 54% and 49% yield from silyl
Correlation with (-)-Esermethole
were installed via alkylation with MeI. The resulting product
was subsequently converted to the alkene via attack with
excess MeMgBr followed by dehydration to form 23. After
installation of the cyanoformamide with carbonyl cyanide,11
cyanoamidation provided the corresponding oxindole 25
(82%, ee 99%). LiAlH4 reduction to the pyrrolidinylindoline
system and reductive amination installing the N-methyl group
(92%, 2 steps) completed the correlation with (-)-esermet-
hole. The stereochemistry of the remaining cyanoamidation
products was assigned in analogy to oxindole 25.
(14) Syntheses of (()-horsfiline or (()-coerulescine: (a) Murphy, J. A.;
Tripoli, R.; Khan, T. A.; Mali, U. W. Org. Lett. 2005, 7, 3287. (b) Chang,
M. Y.; Pai, C.-L.; Kung, Y.-H. Tetrahedron Lett. 2005, 46, 8463. (c) Lizos,
D. E.; Murphy, J. A. Org. Biomol. Chem. 2003, 1, 117. (d) Selvakumar,
N.; Azhagan, A. M.; Srinivas, D.; Krishna, G. G. Tetrahedron Lett. 2002,
43, 9175. (e) Kumar, U. K. S.; Ila, H.; Junjappa, H. Org. Lett. 2001, 3,
4193. (f) Fischer, C.; Meyers, C.; Carreira, E. M. HelV. Chim. Acta 2000,
83, 1175. (g) Bascop, S.; Sapi, J. A.; Laroze, J.; Levy, J. Heterocycles 1994,
(10) Linn, W. J. Org. Synth. 1969, 49, 103.
(11) Martin, E. L. Org. Synth. 1971, 51, 268.
38, 725. (h) Jones, K.; Wilkinson, J. Chem. Commun. 1992, 1767.
(12) Prepared via Fischer esterification of the 5-hydroxyanthranillic acid
according to: Lippa, B.; Kauffman, G. S.; Arcari, J.; Kwan, T.; Chen, J.;
Hunderford, W.; Bhattacharya, S.; Zhao, X.; Williams, C.; Xiao, J.; Pustilnik,
L.; Su, C.; Moyer, J. D.; Ma, L.; Campbell, M.; Steyn, S. Bioorg. Med.
Chem. Lett. 2007, 17, 3081.
(15) Jensen, T.; Pedersen, H.; Bang-Anderson, B.; Madsen, R.; Jør-
gensen, M. Angew. Chem., Int. Ed. 2008, 47, 888–890.
(16) Conditions adapted from the following: Garg, N. K.; Sarpong, R.;
Stoltz, B. M. J. Am. Chem. Soc. 2002, 124, 13179.
(17) Preparation of 30: (a) Kamiya, N.; Chikami, Y.; Ishii, Y. Synlett
1990, 675. (b) Nicolaou, K. C.; Li, Y.; Uesaka, N.; Koftis, T. V.; Vyskocil,
S.; Ling, T.; Govindasamy, M.; Qian, W.; Bernal, F.; Chen, D. Y.-K. Angew.
Chem., Int. Ed. 2003, 42, 3643.
(13) Prior enantioselective syntheses: (a) Trost, B. M.; Brennan, M. K.
Org. Lett. 2006, 8, 2027. (b) Cravotto, G.; Giovenzana, C.; Pilati, T.; Sisti,
M.; Palmisano, G. J. Org. Chem. 2001, 66, 8447. (c) Lakshmaiah, G.;
Kawabata, T.; Shang, M.; Fuji, K. J. Org. Chem. 1999, 64, 1699. (d)
Pellegrini, C.; Stra¨ssler, C.; Weber, M.; Borschberg, H. Tetrahedron:
Asymmetry 1994, 5, 1975.
(18) Satoh, T.; Suzuki, S.; Suzuki, Y.; Miyaji, Y.; Imai, Z. Tetrahedron
Lett. 1969, 10, 4555
.
(19) Zhu, J.; Quirion, J.-C.; Husson, H.-P. J. Org. Chem. 1993, 58, 6451
.
954
Org. Lett., Vol. 12, No. 5, 2010